Nano-Naming No-Nos

Courtesy of Bryan Sugar Nanotechnology has the intellectual property community buzzing about all the potential patentable technology coming out of nanotechnology spin-offs. But many intellectual property practitioners are sitting by idly as they watch this new emerging industry make the same trademark blunders as the last emerging technology, the Internet. The Internet industry, in naming companies, products, and services, placed the prefix "e" before descriptive or generic terms to inform th

Written byBryan Sugar
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Nanotechnology has the intellectual property community buzzing about all the potential patentable technology coming out of nanotechnology spin-offs. But many intellectual property practitioners are sitting by idly as they watch this new emerging industry make the same trademark blunders as the last emerging technology, the Internet.

The Internet industry, in naming companies, products, and services, placed the prefix "e" before descriptive or generic terms to inform the public that the company, product, or service was Internet-related. However, the courts and the US Patent and Trademark Office (USPTO) determined that descriptive or generic terms do not become trademarks just because a descriptive prefix is added to the word. Therefore, many Internet names could not be afforded trademark protection. For example, the USPTO rejected the trademark E-catalog (for computer software used to create an electronic customer order catalog), as well as E-ticket (for computerized reservation and ticketing of transportation services).

Just as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies